Summit Trail Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
13,838
-13,181
-49% -$1.31M 0.02% 767
2026
Q1
$2.54M Buy
27,019
+14,627
+118% +$1.46M 0.04% 395
2025
Q4
$1.22M Buy
12,392
+1,742
+16% +$169K 0.02% 699
2025
Q3
$903K Buy
10,650
+2,796
+36% +$221K 0.01% 890
2025
Q2
$535K Buy
+7,854
New +$498K 0.01% 711
2025
Q1
Sell
-5,452
Closed -$377K 444
2024
Q4
$377K Sell
5,452
-18
-0.3% -$1.28K 0.01% 257
2024
Q3
$362K Buy
+5,470
New +$349K 0.01% 491
2018
Q1
Sell
-684
Closed -$65K 1032
2017
Q4
$65K Buy
+684
New +$71.5K 0.01% 750

Other funds holding INCY

Summit Trail Advisors's INCY Position: Q2 2026 in Review

Summit Trail Advisors reduced its Incyte (INCY) stake by 49% in Q2 2026, selling an estimated $1.31M and leaving 13,838 shares worth $1.57M. The position accounts for 0.02% of the portfolio, ranked #767.

Summit Trail Advisors first reported a position in INCY in Q4 2017 and has held it in 8 quarters since. The position peaked at $2.54M in Q1 2026. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Summit Trail Advisors held 13,838 shares of Incyte worth $1.57M as of Q2 2026.
  • Summit Trail Advisors sold 13,181 Incyte shares in Q2 2026, an estimated $1.31M.
  • Incyte made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #767 holding.
  • Summit Trail Advisors first reported a position in Incyte in Q4 2017 and has held it in 8 quarters since.
  • Summit Trail Advisors's Incyte position peaked at $2.54M in Q1 2026.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.